Removing Barriers to Optimal Breast Cancer Screening May Improve Overall Survival
The researchers looked at what barriers may be contributing to low screening rates among women in Pima County in Southern Arizona.
Conference News
Combining Navigation With Breast Cancer Survivorship Care Plans
More research is needed to better understand how to optimize the utility of survivorship care plans in patients with breast cancer.
A New Risk Calculator for Radiotherapy in Older Women with Early-Stage Breast Cancer
The ROW risk calculator makes its predictions based on age, comorbidities, functional status, tumor characteristics, and use of radiotherapy.
New Study Looks at Quality of Life With NEPA for CINV in Women With Breast Cancer
Quality of life in patients receiving netupitant/palonosetron chemotherapy induced nausea and vomiting.
Severe Lymphedema After Breast Cancer Surgery Associated With Obesity
Although most cases of lymphedema are mild or moderate, obesity and overweight are common factors in women who experience severe lymphedema and HADS-anxiety after breast cancer surgery.
Symptom Management Is Primary Reason Patients With Breast Cancer Seek Medical Cannabis
A review of the Pennsylvania Medical Marijuana Program defined the symptom profile of patients with breast cancer who sought to use medical marijuana.
Patient-Driven Solutions May Lead to Greater Metastatic Breast Cancer Clinical Trial Participation
More patients living with metastatic breast cancer reportedly would be willing to participate in clinical trials if some changes were made.
High Use of Oncology Nurse Navigators Showed Similar Clinical Outcomes for White, Nonwhite Patients With DLBCL
Although previous population-based studies have shown worse clinical outcomes for minority patients with DLBCL compared with white patients, this study reported no differences in PFS and OS were seen between the 2 groups.
Treatment With PI3K Inhibitors Is Associated With a Number of Adverse Events and Toxicities
Despite improved survival in patients with B cell malignancies who are treated with PI3K inhibitors, researchers found incidences of pneumonitis, infections, and sepsis are higher in these patients.
Cumulative Illness Rating Scale Has Prognostic Significance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Researchers found that CIRS scores are prognostic for overall and progression-free survival in patients with R/R DLBCL being evaluated for CAR-T therapy.
